| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UKNOWN |
| UNII: | VE267FC2UB |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Insulin-like growth factor I receptor antagonist | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
| Carcinoma, Large Cell | 3 | D018287 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
| Lung Neoplasms | 1 | D008175 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Sarcoma | 1 | D012509 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Sarcoma, Ewing | 1 | D012512 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1743019 |
| FDA SRS | VE267FC2UB |
CONTENTS